Cargando…
The evolution of the overdose epidemic and CDC’s research response: a commentary
The United States drug overdose epidemic has reached an all-time high, with 2020 provisional mortality data indicating that over 90,000 lives were lost to drug overdose in the 12-months ending in December 2020. The overdose epidemic has evolved over time with respect to the substances involved in ov...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687091/ https://www.ncbi.nlm.nih.gov/pubmed/34970319 http://dx.doi.org/10.7573/dic.2021-8-2 |
_version_ | 1784618147541680128 |
---|---|
author | Holland, Kristin M DePadilla, Lara Gervin, Derrick W Parker, Erin M Wright, Marcienne |
author_facet | Holland, Kristin M DePadilla, Lara Gervin, Derrick W Parker, Erin M Wright, Marcienne |
author_sort | Holland, Kristin M |
collection | PubMed |
description | The United States drug overdose epidemic has reached an all-time high, with 2020 provisional mortality data indicating that over 90,000 lives were lost to drug overdose in the 12-months ending in December 2020. The overdose epidemic has evolved over time with respect to the substances involved in overdose deaths and also with respect to the geographic distribution and epidemiology of deaths involving specific substances. Thus, a nimble approach to addressing the epidemic and preventing future overdoses is needed. CDC’s response to the overdose epidemic supports implementation efforts at the state and local levels, where partners can better detect and respond to the evolving drug overdose landscape and implement prevention measures that meet their needs. CDC’s framework for responding to the overdose epidemic focuses on five areas: (1) conducting surveillance and research; (2) building state, local and tribal capacity; (3) supporting providers, health systems and payers; (4) partnering with public safety; and (5) empowering consumers to make safe choices. Central to informing the implementation of evidence-based strategies to prevent drug overdose is rigorous research that undergirds the evidence. This Commentary describes recent investments in overdose prevention research and outlines opportunities for ensuring that future research efforts allow for the flexibility necessary to effectively respond to the continually evolving epidemic. |
format | Online Article Text |
id | pubmed-8687091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioExcel Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-86870912021-12-29 The evolution of the overdose epidemic and CDC’s research response: a commentary Holland, Kristin M DePadilla, Lara Gervin, Derrick W Parker, Erin M Wright, Marcienne Drugs Context Commentary The United States drug overdose epidemic has reached an all-time high, with 2020 provisional mortality data indicating that over 90,000 lives were lost to drug overdose in the 12-months ending in December 2020. The overdose epidemic has evolved over time with respect to the substances involved in overdose deaths and also with respect to the geographic distribution and epidemiology of deaths involving specific substances. Thus, a nimble approach to addressing the epidemic and preventing future overdoses is needed. CDC’s response to the overdose epidemic supports implementation efforts at the state and local levels, where partners can better detect and respond to the evolving drug overdose landscape and implement prevention measures that meet their needs. CDC’s framework for responding to the overdose epidemic focuses on five areas: (1) conducting surveillance and research; (2) building state, local and tribal capacity; (3) supporting providers, health systems and payers; (4) partnering with public safety; and (5) empowering consumers to make safe choices. Central to informing the implementation of evidence-based strategies to prevent drug overdose is rigorous research that undergirds the evidence. This Commentary describes recent investments in overdose prevention research and outlines opportunities for ensuring that future research efforts allow for the flexibility necessary to effectively respond to the continually evolving epidemic. BioExcel Publishing Ltd 2021-12-15 /pmc/articles/PMC8687091/ /pubmed/34970319 http://dx.doi.org/10.7573/dic.2021-8-2 Text en Copyright © 2021 Holland KM, DePadilla L, Gervin DW, Parker EM, Wright M https://creativecommons.org/licenses/by-nc-nd/4.0/Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission. |
spellingShingle | Commentary Holland, Kristin M DePadilla, Lara Gervin, Derrick W Parker, Erin M Wright, Marcienne The evolution of the overdose epidemic and CDC’s research response: a commentary |
title | The evolution of the overdose epidemic and CDC’s research response: a commentary |
title_full | The evolution of the overdose epidemic and CDC’s research response: a commentary |
title_fullStr | The evolution of the overdose epidemic and CDC’s research response: a commentary |
title_full_unstemmed | The evolution of the overdose epidemic and CDC’s research response: a commentary |
title_short | The evolution of the overdose epidemic and CDC’s research response: a commentary |
title_sort | evolution of the overdose epidemic and cdc’s research response: a commentary |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687091/ https://www.ncbi.nlm.nih.gov/pubmed/34970319 http://dx.doi.org/10.7573/dic.2021-8-2 |
work_keys_str_mv | AT hollandkristinm theevolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT depadillalara theevolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT gervinderrickw theevolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT parkererinm theevolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT wrightmarcienne theevolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT hollandkristinm evolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT depadillalara evolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT gervinderrickw evolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT parkererinm evolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary AT wrightmarcienne evolutionoftheoverdoseepidemicandcdcsresearchresponseacommentary |